kabutan

Takeda Pharmaceutical Company Limited(4502) Summary

4502
TSE Prime
Takeda Pharmaceutical Company Limited
5,137
JPY
+55
(+1.08%)
Jan 29, 1:37 pm JST
33.56
USD
Jan 28, 11:37 pm EST
Result
PTS
outside of trading hours
5,135.2
Jan 29, 1:36 pm JST
Summary Chart Historical News Financial Result
PER
53.0
PBR
1.14
Yield
3.89%
Margin Trading Ratio
18.16
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
5,112 JPY 33.38 USD
Previous Close Jan 28
5,082 JPY 33.29 USD
High Jan 29, 1:35 pm
5,140 JPY 33.58 USD
Low Jan 29, 9:01 am
5,085 JPY 33.21 USD
Volume
3,641,500
Trading Value
0.02T JPY 0.12B USD
VWAP
5111.4 JPY 33.4 USD
Minimum Trading Value
513,700 JPY 3,356 USD
Market Cap
8.17T JPY 0.05T USD
Number of Trades
7,750
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
5,618
1-Year High Apr 7, 2025
25,323
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 296,000 899,600 3.04
Jan 16, 2026 340,500 837,300 2.46
Jan 9, 2026 427,400 694,500 1.62
Dec 26, 2025 426,500 683,000 1.60
Dec 19, 2025 247,100 731,200 2.96
Company Profile
Takeda Pharmaceutical Company Limited is a leading pharmaceutical company. With the acquisition of Shire, it has become a global industry leader. The company focuses on prescription drugs and is strengthening its development of new cancer medications.
Sector
Pharmaceuticals
Takeda Pharmaceutical Company Limited's main business is the research, development, manufacturing, and sales of pharmaceuticals, with a focus on key business areas including gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. The company's research and development efforts are concentrated on three areas: innovative biopharmaceuticals in the priority disease areas of gastroenterology and inflammatory diseases, neuroscience, and oncology, along with plasma-derived therapies and vaccines. Takeda is also committed to rare diseases. The company invests in new research and development capabilities and next-generation platforms, leveraging data and digital technologies to enhance innovation quality and accelerate execution. In Japan, Takeda conducts all operations from research and development to sales in-house, while overseas subsidiaries and affiliates handle manufacturing and sales functions in their respective countries.